Hematocrit levels and physiologic factors in relationship to cardiovascular risk in Tecumseh, Michigan.

PubWeight™: 0.84‹?›

🔗 View Article (PMID 8064170)

Published in J Hypertens on April 01, 1994

Authors

S Smith1, S Julius, K Jamerson, J Amerena, N Schork

Author Affiliations

1: Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor 48109-0356.

Articles by these authors

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group. Lancet (1998) 26.64

Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA (2001) 4.75

"White coat" versus "sustained" borderline hypertension in Tecumseh, Michigan. Hypertension (1990) 3.30

Singleton deletions throughout the genome increase risk of bipolar disorder. Mol Psychiatry (2008) 2.50

Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment. Nat Genet (1999) 2.37

Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Am Heart J (1973) 2.17

Home blood pressure determination. Value in borderline ("labile") hypertension. JAMA (1974) 2.16

The 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. Blood Press (1993) 2.03

Reference values for self-recorded blood pressure: a meta-analysis of summary data. Arch Intern Med (1998) 2.01

Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94

Home blood pressure monitoring. Arch Intern Med (2000) 1.71

Current management of acute coronary syndromes in Australia: observations from the acute coronary syndromes prospective audit. Intern Med J (2007) 1.63

High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med (1999) 1.62

Type II diabetes, essential hypertension, and obesity as "syndromes of impaired genetic homeostasis": the "thrifty genotype" hypothesis enters the 21st century. Perspect Biol Med (1998) 1.57

Heart rate and the cardiovascular risk. J Hypertens (1997) 1.57

Are left ventricular mass, geometry and function related to vascular changes and/or insulin resistance in long-standing hypertension? ICARUS: a LIFE substudy. J Hum Hypertens (2003) 1.51

Elevated heart rate: a major risk factor for cardiovascular disease. Clin Exp Hypertens (2005) 1.49

Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension (1993) 1.48

Lead, hypertension, and the renin-angiotensin system in rats. J Lab Clin Med (1982) 1.45

Predictors of new-onset diabetes mellitus in hypertensive patients: the VALUE trial. J Hum Hypertens (2008) 1.44

Comparison of phenotype between patients with Prader-Willi syndrome due to deletion 15q and uniparental disomy 15. Am J Med Genet (1997) 1.35

Diagnostic significance of abdominal murmurs. N Engl J Med (1967) 1.29

The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group. Am J Hypertens (1997) 1.28

Hemodynamic effects of acute and prolonged beta-adrenergic blockade in essential hypertension. Acta Med Scand (1974) 1.28

Relationship between cardiac output and peripheral resistance in borderline hypertension. Circulation (1971) 1.23

Influence of age on the hemodynamic response to exercise. Circulation (1967) 1.22

Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension (1997) 1.22

Mild high-renin essential hypertension. Neurogenic human hypertension? N Engl J Med (1977) 1.18

Role of parasympathetic inhibition in the hyperkinetic type of borderline hypertension. Circulation (1971) 1.15

Impact of ethnicity on left ventricular mass and relative wall thickness in essential hypertension. Am J Cardiol (1998) 1.12

Hemodynamic studies in patients with borderline blood pressure elevation. Circulation (1968) 1.11

Sex-specific determinants of increased left ventricular mass in the Tecumseh Blood Pressure Study. Circulation (1994) 1.10

Hemodynamic responses to tilt and beta-adrenergic blockade in young patients with borderline hypertension. Circulation (1970) 1.10

Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE study. Losartan Intervention For End point. J Am Coll Cardiol (2001) 1.10

Relationships between metrics of visit-to-visit variability of blood pressure. J Hum Hypertens (2013) 1.08

Easy money? Health cost savings resulting from the switch from a branded drug to a low-cost generic drug in the same class. Int J Clin Pract (2011) 1.07

Baseline characteristics in relation to electrocardiographic left ventricular hypertrophy in hypertensive patients: the Losartan intervention for endpoint reduction (LIFE) in hypertension study. The Life Study Investigators. Hypertension (2000) 1.07

Convergent functional genomics of anxiety disorders: translational identification of genes, biomarkers, pathways and mechanisms. Transl Psychiatry (2011) 1.06

Association of tachycardia with morbidity and mortality: pathophysiological considerations. J Hum Hypertens (1997) 1.06

Blood pressure in genetically hypertensive rats. Influence of the Y chromosome. Hypertension (1995) 1.05

Effect of beta-adrenergic blockade on plasma volume in human subjects. Proc Soc Exp Biol Med (1972) 1.03

The international database of self-recorded blood pressures in normotensive and untreated hypertensive subjects. Blood Press Monit (1999) 1.03

The association of borderline hypertension with target organ changes and higher coronary risk. Tecumseh Blood Pressure study. JAMA (1990) 1.03

Autonomic imbalance, hypertension, and cardiovascular risk. Am J Hypertens (2000) 1.02

Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension. J Clin Invest (1987) 1.02

Effect of beta adrenoceptor antagonists on baroreceptor reflex sensitivity in hypertension. Clin Pharmacol Ther (1977) 1.01

Autonomic nervous cardiovascular regulation in borderline hypertension. Am J Cardiol (1975) 1.01

Borderline hypertension--a critical review. J Chronic Dis (1971) 1.00

Angiotensin mediates forearm glucose uptake by hemodynamic rather than direct effects. Hypertension (1996) 1.00

The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Press (1992) 1.00

Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension. Hypertension (1998) 0.99

Relation of echocardiographic left ventricular mass and hypertrophy to persistent electrocardiographic left ventricular hypertrophy in hypertensive patients: the LIFE Study. Am J Hypertens (2001) 0.99

Influence of hypertension on the hemodynamic response to exercise. Circulation (1967) 0.97

Racial differences in erythrocyte cation transport. Hypertension (1984) 0.93

The Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial of cardiovascular events in hypertension. Rationale and design. Blood Press (1998) 0.92

The effect of baseline physical activity on cardiovascular outcomes and new-onset diabetes in patients treated for hypertension and left ventricular hypertrophy: the LIFE study. J Intern Med (2007) 0.92

Increased platelet catecholamine content in pheochromocytoma: a diagnostic test in patients with elevated plasma catecholamines. N Engl J Med (1982) 0.92

Effect of home blood pressure and gender on estimates of the familial aggregation of blood pressure. The Tecumseh Blood Pressure Study. Hypertension (1992) 0.92

Hypertension optimal treatment (HOT) study: home blood pressure in treated hypertensive subjects. Hypertension (1998) 0.91

Genetic contribution to the variance in left ventricular mass: the Tecumseh Offspring Study. J Hypertens (2001) 0.91

Vasoconstriction with norepinephrine causes less forearm insulin resistance than a reflex sympathetic vasoconstriction. Hypertension (1994) 0.90

Sympathetics, insulin resistance and coronary risk in hypertension: the 'chicken-and-egg' question. J Hypertens (1994) 0.90

White coat hypertension: a follow-up. Clin Exp Hypertens A (1992) 0.90

Mapping of a blood pressure quantitative trait locus to chromosome 15q in a Chinese population. Hum Mol Genet (1999) 0.90

Disease entities, mixed multi-normal distributions, and the role of the hyperkinetic state in the pathogenesis of hypertension. Stat Med (1990) 0.89

Home blood pressure monitoring. Current knowledge and directions for future research. Blood Press (2001) 0.89

Relationship of age and blood pressure to baroreflex sensitivity and arterial compliance in man. Clin Sci Mol Med Suppl (1976) 0.89

Stroke volume--pulse pressure relationships in borderline hypertension: a possible indicator of decreased arterial compliance. J Hypertens Suppl (1984) 0.89

Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study. J Hum Hypertens (2004) 0.89

Altered cardiac responsiveness and regulation in the normal cardiac output type of borderlind hlpertension. Circ Res (1975) 0.88

Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials. Blood Press (2001) 0.88

The hemodynamic link between insulin resistance and hypertension. J Hypertens (1991) 0.87

University of California, Davis, conference: Mild hypertension. Am J Med (1988) 0.87

Determinants of baroreflex sensitivity in man. J Lab Clin Med (1978) 0.87

Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number. Clin Pharmacol Ther (1985) 0.87

Abnormalities of plasma volume in borderline hypertension. Arch Intern Med (1971) 0.86

Usefulness of home BP determination in treating borderline hypertension. JAMA (1982) 0.86

Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans. Hypertension (1983) 0.85

Role of cardiac factors in the initial hypotensive action by beta-adrenoreceptor blocking agents. Hypertension (1984) 0.85

Vascular structure enhances regional resistance responses in mild essential hypertension. J Hypertens (1988) 0.85

Effect of circulating epinephrine on platelet function and hematocrit. Hypertension (1995) 0.85

Evidence against an interaction of angiotensin II with the sympathetic nervous system in man. Clin Endocrinol (Oxf) (1981) 0.85

Syndrome X: is it for real? Genet Epidemiol (1998) 0.85

Relation of renin status to neurogenic vascular resistance in borderline hypertension. Am J Cardiol (1975) 0.85

The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens (1999) 0.85

Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens (1997) 0.85

Relevance of heart rate as a risk factor in hypertension. Curr Hypertens Rep (1999) 0.85

Suppression of sympathetic nervous function in low-renin essential hypertension. Lancet (1976) 0.84

Hemodynamic effects of angiotensin-converting enzyme inhibitors in essential hypertension: a review. J Cardiovasc Pharmacol (1985) 0.84

Metabolic adverse effects of thiazide diuretics: the importance of normokalaemia. J Intern Med Suppl (1991) 0.83

Plasma norepinephrine variations with dietary sodium intake. Hypertension (1980) 0.83

Heritability of left atrial size in the Tecumseh population. Eur J Clin Invest (2002) 0.83